<DOC>
	<DOCNO>NCT00014599</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . PURPOSE : Phase II trial study effectiveness paclitaxel treat patient locally advance , metastatic , recurrent cancer vulva .</brief_summary>
	<brief_title>Paclitaxel Treating Patients With Locally Advanced , Metastatic , Recurrent Cancer Vulva</brief_title>
	<detailed_description>OBJECTIVES : - Determine therapeutic activity paclitaxel patient locally advance , metastatic , recurrent squamous cell carcinoma vulva . - Determine objective response rate duration response patient treated drug . - Determine acute side effect drug patient . OUTLINE : This multicenter study . Patients receive paclitaxel IV 3 hour day 1 . Treatment repeat every 21 day maximum 10 course absence disease progression unacceptable toxicity . Patients follow every 9 week . PROJECTED ACCRUAL : A total 16-29 patient accrue study .</detailed_description>
	<mesh_term>Vulvar Neoplasms</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm squamous cell carcinoma vulva Not suitable radiotherapy surgery firstline treatment Measurable evaluable disease At least 1 bidimensionally measurable target lesion Measurable metastatic disease outside previously irradiate area OR Local recurrence within previously treat area OR Local lesion show progression treatment No brain metastasis PATIENT CHARACTERISTICS : Age : 18 Performance status : WHO 02 ECOG 02 Life expectancy : At least 3 month Hematopoietic : Not specify Hepatic : Bilirubin great 1.5 mg/dL AST/ALT le 2 time upper limit normal Renal : Creatinine clearance great 60 mL/min Cardiovascular : No prior concurrent cardiac disease ( i.e. , uncontrolled high blood pressure , unstable angina , congestive heart failure , myocardial infarction within past year , cardiac ventricular arrhythmia require medication , 2nd 3rd degree heart block ) Other : No peripheral neuropathy great grade 1 No serious active infection No prior allergic reaction drug contain Cremophor EL No serious medical , psychological , familial , social condition would preclude study Not pregnant nursing Fertile patient must use effective contraception PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : No prior chemotherapy except concurrent therapy radiotherapy Endocrine therapy : Not specify Radiotherapy : See Disease Characteristics See Chemotherapy No concurrent radiotherapy Surgery : Not specify</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>stage III vulvar cancer</keyword>
	<keyword>stage IV vulvar cancer</keyword>
	<keyword>recurrent vulvar cancer</keyword>
	<keyword>squamous cell carcinoma vulva</keyword>
</DOC>